ShareThis Page
Health

Pittsburgh researchers awarded $1M grant for breast cancer research

Emily Balser
| Friday, Nov. 9, 2018, 11:00 a.m.
Breast Cancer Research Foundation grant recipients from left to right are Adrian Lee, Leisha Emens, Steffi Oesterreich and Wendie Berg.
Submitted
Breast Cancer Research Foundation grant recipients from left to right are Adrian Lee, Leisha Emens, Steffi Oesterreich and Wendie Berg.

Four UPMC Hillman Cancer Center and University of Pittsburgh researchers have received a $1 million grant for breast cancer research.

The grant is part of a $63 million investment in cancer research by the Breast Cancer Research Foundation.

The money will be used for all areas of breast cancer research, from the most basic biology of a cancer cell to developing innovative new treatments and improving quality of life.

Researchers Wendie Berg, Leisha Emens, Steffi Oesterreich and Adrian Lee will split the grant money.

Berg’s area of research includes improving the precision of breast cancer detection and examining the role of whole breast screening ultrasound for detecting breast cancer in women with dense breasts following 3D mammography.

Emens led the first large clinical trial demonstrating the clinical activity of immunotherapy in patients with triple negative breast cancer. Her research aims to develop highly effective combination immunotherapies.

Oesterreich’s research has focused on understanding unique features of invasive lobular breast cancer, the second most common histological subtype of breast cancer.

Lee’s BCRF-funded research focuses on targeting the insulin-like growth factor pathway in E-cadherin deficient breast cancers.

The grants were awarded to 300 scientists at academic and medical institutions across 14 countries and six continents.

Emily Balser is a Tribune-Review staff writer. You can contact Emily at 724-226-4680, emilybalser@tribweb.com or via Twitter @emilybalser.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.

click me